Both medications have their roles in obesity management, and the choice between the two will often fall on individual patient needs, preferences, medical history, and a healthcare providers recommendation
GLP-1 medicines can slow stomach emptying
Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis
Microdosing GLP-1s is hardly a one-size fits all process, and its important to use a telehealth platform that offers a truly personalized plan
Written by Naomi Crabtree Quality Assurance Specialist & Research Consultant Renew Lab Group Naomi specializes in pharmaceutical quality assurance, HPLC analysis, and USP compendial testing
With Belos expert guidance, you can achieve your body goals safely and effectively